mHealth intervention and health-related quality of life for haemodialysis patients in selected counties of Kenya
Keywords:mHealth, Haemodialysis, Health related QoL
Increasingly, chronic kidney disease (CKD) is becoming a public health challenge ranking 12th most common cause of death in the world. Prolonged CKD leads to end stage renal disease ultimately requiring dialysis. Undoubtedly, end stage renal disease significantly reduces health related quality of life (QoL). Many haemodialysis patients in Africa lack focused educational and follow up support in their treatment journey due to weak health systems. Evidence shows potential benefits of mHealth in improving overall medical outcomes among haemodialysis patients. Despite foreseeable benefits of mHealth, scanty information is available on its effectiveness in improving knowledge, treatment adherence, lifestyle change and overall health related QoL in Kenya. The general objective of this study will be to establish the effect of mHealth intervention on health-related QoL for haemodialysis patients. The specific objectives will be to study the effect of mHealth on: knowledge of self-management, adherence to haemodialysis treatment, stress management, life style change for haemodialysis patients and the combined effect of mHealth on health-related QoL. The study design will be quasi experimental with intervention and control sites. Data will be described using proportions, means, medians and other measures of central tendency. Effect will be quantified by use of student t tests, odds ratios, and difference in differences statistics. Its envisaged that the findings of this study will redound to development of large scale mHealth based medical education platform for haemodialysis patients with potential for scale as a critical public health intervention.
Definition and classification of CKD. In: Kidney International Supplements. Elsevier Inc; 2013;3:19-62.
Johnson C, Levey A, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: part I definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004;70(5):869-76.
Singh S, Sharma R, Kumari M, Tiwari S. Insulin receptors in the kidneys in health and disease. World J Nephrol. 2019;8(1):11-22.
Mousa I, Ataba R, Al-ali K, Alkaiyat A, Zyoud SH. Dialysis-related factors affecting self-efficacy and quality of life in patients on haemodialysis: a cross-sectional study from Palestine. Ren Replace Ther. 2018;4(1):1-12.
Wang H, Naghavi M, Allen C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544.
Kassebaum NJ, Arora M, Barber RM. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603-58.
Perico N, Remuzzi G. Chronic kidney disease in sub-Saharan Africa: A public health priority. Lancet Glob Heal. 2014;2(3):124-5.
Dwyer-Lindgren L, Cork MA, Sligar A. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570(7760):189-93.
George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: The case f increased screening. BMJ Glob Heal. 2017;2(2):1-10.
Naicker S, Ashuntantang G. End Stage Renal Disease in Sub-Saharan Africa. Chronic Kidney Dis Disadvantaged Popul. Published online. 2017;125-37.
Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease on the African continent: A systematic review and meta-analysis. BMC Nephrol. 2018;19(1):1-11.
Kalyesubula R, Nankabirwa JI, Ssinabulya I, et al. Kidney disease in Uganda: a community based study. BMC Nephrol. 2017;18(1):1-9.
Mugo P, Onsomu E, Munga B. An Assessment of Healthcare Delivery in Kenya under the Devolved System An Assessment Healthcare Delivery. 2018;19.
Mwangi. Kenya-Medical Equipment. export.gov. Available at: https://www.export.gov/article?id= Kenya-medical-equipment. Published 2019. Accessed on September 29, 2019.
Beerappa H, Chandrababu R. Adherence to dietary and fluid restrictions among patients undergoing hemodialysis: An observational study. Clin Epidemiol Glob Heal. 2019;7(1):127-30.
Karimi M, Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? Pharmacoeconomics. 2016;34(7):645-9.
Chege P. Multiple cardiovascular disease risk factors in rural Kenya: evidence from a health and demographic surveillance system using the WHO STEP-wise approach to chronic disease risk factor surveillance. South African Fam Pract. 2016;58(2):54-61.
Oluyombo R, Ayodele OE, Akinwusi PO. Awareness, knowledge and perception of chronic kidney disease in a rural community of South-West Nigeria. Niger J Clin Pract. 2016;19(2):161-9.
Wileman V, Farrington K, Wellsted D, Almond M, Davenport A, Chilcot J. Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients. Br J Health Psychol. 2015;20(3):563-78.
WHO. eHealth at WHO. WHO. Published online 2018. Available at: https://www.who.int/ehealth/ about/en/Accessed on October 23, 2019.
Singh, Panjwani, Puri, Delhi N. mHealth : Meaning , Purpose and Outcomes. Int J Comput Sci Inf Technol. 2016;7(5):2216-21.
Lingala SM, Ghany MGMMhs. Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management. 2017;25(3):289-313.
Kariuki EG. Adoption of m-health and usability challenges in m-health applications in kenya: case of uzazi poa m-health prototype application. J Econ Financ. 2016;3(1):56.
WHO. Image based information access for mobile phones. Proc-Int Work Content-Based Multimed Index. 2011;3:130-5.